Literature Collection

Collection Insights

10K+

References

9K+

Articles

1400+

Grey Literature

4500+

Opioids & SU

The Literature Collection contains over 10,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Year
Sort by
Order
Show
3817 Results
222
A randomized trial of collaborative depression care in obstetrics and gynecology clinics: socioeconomic disadvantage and treatment response
Type: Journal Article
Authors: W. Katon, J. Russo, S. D. Reed, C. A. Croicu, E. Ludman, A. LaRocco, J. L. Melville
Year: 2015
Publication Place: United States
Abstract: OBJECTIVE: The authors evaluated whether an obstetrics-gynecology clinic-based collaborative depression care intervention is differentially effective compared with usual care for socially disadvantaged women with either no health insurance or with public coverage compared with those with commercial insurance. METHOD: The study was a two-site randomized controlled trial with an 18-month follow-up. Women were recruited who screened positive (a score of at least 10 on the Patient Health Questionnaire-9) and met criteria for major depression or dysthymia. The authors tested whether insurance status had a differential effect on continuous depression outcomes between the intervention and usual care over 18 months. They also assessed differences between the intervention and usual care in quality of depression care and dichotomous clinical outcomes (a decrease of at least 50% in depressive symptom severity and patient-rated improvement on the Patient Global Improvement Scale). RESULTS: The treatment effect was significantly associated with insurance status. Compared with patients with commercial insurance, those with no insurance or with public coverage had greater recovery from depression symptoms with collaborative care than with usual care over the 18-month follow-up period. At the 12-month follow-up, the effect size for depression improvement compared with usual care among women with no insurance or with public coverage was 0.81 (95% CI=0.41, 0.95), whereas it was 0.39 (95% CI=-0.08, 0.84) for women with commercial insurance. CONCLUSIONS: Collaborative depression care adapted to obstetrics-gynecology settings had a greater impact on depression outcomes for socially disadvantaged women with no insurance or with public coverage compared with women with commercial insurance.
Topic(s):
Healthcare Disparities See topic collection
,
Financing & Sustainability See topic collection
,
Education & Workforce See topic collection
223
A Randomized Trial to Reduce the Prevalence of Depression and Self-Harm Behavior in Older Primary Care Patients
Type: Journal Article
Authors: O. P. Almeida, J. Pirkis, N. Kerse, M. Sim, L. Flicker, J. Snowdon, B. Draper, G. Byrne, R. Goldney, N. T. Lautenschlager, N. Stocks, H. Alfonso, J. J. Pfaff
Year: 2012
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
224
A randomized, controlled trial of disease management modules, including telepsychiatric care, for depression in rural primary care
Type: Journal Article
Authors: D. M. Hilty, S. Marks, J. Wegeland, E. J. Callahan, T. S. Nesbitt
Year: 2007
Topic(s):
Healthcare Disparities See topic collection
226
A rapid access to addiction medicine clinic facilitates treatment of substance use disorder and reduces substance use
Type: Journal Article
Authors: D. Wiercigroch, H. Sheikh, J. Hulme
Year: 2020
Abstract:

BACKGROUND: Substance use is prevalent in Canada, yet treatment is inaccessible. The Rapid Access to Addiction Medicine (RAAM) clinic opened at the University Health Network (UHN) in January 2018 as part of a larger network of addictions clinics in Toronto, Ontario, to enable timely, low barrier access to medical treatment for substance use disorder (SUD). Patients attend on a walk-in basis without requiring an appointment or referral. We describe the RAAM clinic model, including referral patterns, patient demographics and substance use patterns. Secondary outcomes include retention in treatment and changes in both self-reported and objective substance use. METHODS: The Electronic Medical Record at the clinic was reviewed for the first 26 weeks of the clinic's operation. We identified SUD diagnoses, referral source, medications prescribed, retention in care and self-reported substance use. RESULTS: The clinic saw 64 unique patients: 66% had alcohol use disorder (AUD), 39% had opiate use disorder (OUD) and 20% had stimulant use disorder. Fifty-five percent of patients were referred from primary care providers, 30% from the emergency department and 11% from withdrawal management services. Forty-two percent remained on-going patients, 23% were discharged to other care and 34% were lost to follow-up. Gabapentin (39%), naltrexone (39%), and acamprosate (15%) were most frequently prescribed for AUD. Patients with AUD reported a significant decrease in alcohol consumption at their most recent visit. Most patients (65%) with OUD were prescribed buprenorphine, and most patients with OUD (65%) had a negative urine screen at their most recent visit. CONCLUSION: The RAAM model provides low-barrier, accessible outpatient care for patients with substance use disorder and facilitates the prescription of evidence-based pharmacotherapy for AUD and OUD. Patients referred by their primary care physician and the emergency department demonstrated a reduction in median alcohol consumption and high rates of opioid abstinence.

Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
227
A realist review of best practices and contextual factors enhancing treatment of opioid dependence in Indigenous contexts
Type: Journal Article
Authors: R. Henderson, A. McInnes, A. Danyluk, I. Wadsworth, B. Healy, L. Crowshoe
Year: 2023
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
228
A Regional Survey on Residents' Preferences on Patient-Centered Medical Home Design in Rural Areas
Type: Journal Article
Authors: Hui Cai, Kent Spreckelmeyer, Amy Mendenhall, Dan Li, Cheryl Holmes, Michelle Levy
Year: 2019
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Medical Home See topic collection
230
A research agenda for adolescent-centered primary care in the United States
Type: Journal Article
Authors: H. B. Fox, M. A. McManus, C. E. Irwin Jr, K. J. Kelleher, K. Peake
Year: 2013
Publication Place: United States
Topic(s):
Financing & Sustainability See topic collection
,
Healthcare Disparities See topic collection
231
A Retrospective Cohort Study of Obstetric Outcomes in Opioid-Dependent Women Treated with Implant Naltrexone, Oral Methadone or Sublingual Buprenorphine, and Non-Dependent Controls
Type: Journal Article
Authors: E. Kelty, G. Hulse
Year: 2017
Publication Place: New Zealand
Abstract: BACKGROUND: Opioid pharmacotherapies play an important role in the treatment of opioid-dependent women; however, very little is known about the safety of naltrexone in pregnant patients. OBJECTIVE: This study examined the obstetric health of opioid-dependent women who were treated with implant naltrexone during pregnancy, and compared them with women treated with methadone and/or buprenorphine and a cohort of non-opioid-dependent controls. METHODS: Women treated with implant naltrexone, oral methadone or sublingual buprenorphine between 2001 and 2010, along with a cohort of age-matched controls, were linked with records from midwives, hospital and emergency departments (EDs) and the death registry to identify pregnancy and health events that occurred during pregnancy and in the post-partum period. RESULTS: Overall rates of pregnancy loss (requiring hospital or ED attendance) were significantly elevated in naltrexone-treated women compared with buprenorphine-treated women (p = 0.018) and controls (p < 0.001); however, they were not statistically different to methadone-treated women (p = 0.210). Birth rates in women on naltrexone implant treatment were significantly higher than in all three comparison groups (p < 0.001). Rates of hospital and ED attendance during pregnancy in the naltrexone-treated women were not statistically different to those of either the methadone or buprenorphine groups, and neither were overall complications during pregnancy and labour. Overall rates of complications during pregnancy were significantly higher in the naltrexone-treated women than in the controls. CONCLUSION: Opioid-dependent women treated with naltrexone implant had higher rates of birth than the other three groups (methadone- or buprenorphine-treated women, or age-matched controls). Overall rates of complications during pregnancy were elevated in naltrexone-treated women when compared with the control group, but were generally not significantly different to rates in methadone- or buprenorphine-treated women.
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
232
A Retrospective Cohort Study of Obstetric Outcomes in Opioid-Dependent Women Treated with Implant Naltrexone, Oral Methadone or Sublingual Buprenorphine, and Non-Dependent Controls
Type: Journal Article
Authors: E. Kelty, G. Hulse
Year: 2017
Publication Place: New Zealand
Abstract: BACKGROUND: Opioid pharmacotherapies play an important role in the treatment of opioid-dependent women; however, very little is known about the safety of naltrexone in pregnant patients. OBJECTIVE: This study examined the obstetric health of opioid-dependent women who were treated with implant naltrexone during pregnancy, and compared them with women treated with methadone and/or buprenorphine and a cohort of non-opioid-dependent controls. METHODS: Women treated with implant naltrexone, oral methadone or sublingual buprenorphine between 2001 and 2010, along with a cohort of age-matched controls, were linked with records from midwives, hospital and emergency departments (EDs) and the death registry to identify pregnancy and health events that occurred during pregnancy and in the post-partum period. RESULTS: Overall rates of pregnancy loss (requiring hospital or ED attendance) were significantly elevated in naltrexone-treated women compared with buprenorphine-treated women (p = 0.018) and controls (p < 0.001); however, they were not statistically different to methadone-treated women (p = 0.210). Birth rates in women on naltrexone implant treatment were significantly higher than in all three comparison groups (p < 0.001). Rates of hospital and ED attendance during pregnancy in the naltrexone-treated women were not statistically different to those of either the methadone or buprenorphine groups, and neither were overall complications during pregnancy and labour. Overall rates of complications during pregnancy were significantly higher in the naltrexone-treated women than in the controls. CONCLUSION: Opioid-dependent women treated with naltrexone implant had higher rates of birth than the other three groups (methadone- or buprenorphine-treated women, or age-matched controls). Overall rates of complications during pregnancy were elevated in naltrexone-treated women when compared with the control group, but were generally not significantly different to rates in methadone- or buprenorphine-treated women.
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
233
A retrospective study of retention of opioid-dependent adolescents and young adults in an outpatient buprenorphine/naloxone clinic.
Type: Journal Article
Authors: Steven C. Matson, Gerrit Hobson, Mahmoud Abdel-Rasoul, Andrea E. Bonny
Year: 2014
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
235
A retrospective, observational study on medication for opioid use disorder during pregnancy and risk for neonatal abstinence syndrome
Type: Journal Article
Authors: Ayesha Sujan, Emma Cleary, Edie Douglas, Rubin Aujla, Lisa Boyars, Claire Smith, Constance Guille
Year: 2022
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
238
A review of contingency management for the treatment of substance-use disorders: adaptation for underserved populations, use of experimental technologies, and personalized optimization strategies
Type: Journal Article
Authors: S. M. McPherson, E. Burduli, C. L. Smith, J. Herron, O. Oluwoye, K. Hirchak, M. F. Orr, M. G. McDonell, J. M. Roll
Year: 2018
Abstract: This review of contingency management (CM; the behavior-modification method of providing reinforcement in exchange for objective evidence of a desired behavior) for the treatment of substance-use disorders (SUDs) begins by describing the origins of CM and how it has come to be most commonly used during the treatment of SUDs. Our core objective is to review, describe, and discuss three ongoing critical advancements in CM. We review key emerging areas wherein CM will likely have an impact. In total, we qualitatively reviewed 31 studies in a systematic fashion after searching PubMed and Google Scholar. We then describe and highlight CM investigations across three broad themes: adapting CM for underserved populations, CM with experimental technologies, and optimizing CM for personalized interventions. Technological innovations that allow for mobile delivery of reinforcers in exchange for objective evidence of a desired behavior will likely expand the possible applications of CM throughout the SUD-treatment domain and into therapeutically related areas (eg, serious mental illness). When this mobile technology is coupled with new, easy-to-utilize biomarkers, the adaptation for individual goal setting and delivery of CM-based SUD treatment in hard-to-reach places (eg, rural locations) can have a sustained impact on communities most affected by these disorders. In conclusion, there is still much to be done, not only technologically but also in convincing policy makers to adopt this well-established, cost-effective, and evidence-based method of behavior modification.
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
239
A review of opioid-based treatments for gambling disorder: An examination of treatment outcomes, cravings, and individual differences
Type: Journal Article
Authors: Darren R. Christensen
Year: 2018
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
240
A review of the benefits and limitations of a primary care-embedded psychiatric consultation service in a medically underserved setting
Type: Journal Article
Authors: Dennis J. Butler, Dominique Fons, Travis Fisher, James Sanders, Sara Bodenhamer, Julie R. Owen, Marc Gunderson
Year: 2018
Publication Place: United States
Abstract:

A significant percentage of patients with psychiatric disorders are exclusively seen for health-care services by primary care physicians. To address the mental health needs of such patients, collaborative models of care were developed including the embedded psychiatry consult model which places a consultant psychiatrist on-site to assist the primary care physician to recognize psychiatric disorders, prescribe psychiatric medication, and develop management strategies. Outcome studies have produced ambiguous and inconsistent findings regarding the impact of this model. This review examines a primary care-embedded psychiatric consultation service in place for nine years in a family medicine residency program. Psychiatric consultants, family physicians, and residents actively involved in the service participated in structured interviews designed to identify the clinical and educational value of the service. The benefits and limitations identified were then categorized into physician, consultant, patient, and systems factors. Among the challenges identified were inconsistent patient appointment-keeping, ambiguity about appropriate referrals, consultant scope-of-practice parameters, and delayed follow-up with consultation recommendations. Improved psychiatric education for primary care physicians also appeared to shift referrals toward more complex patients. The benefits identified included the availability of psychiatric services to underserved and disenfranchised patients, increased primary care physician comfort with medication management, and improved interprofessional communication and education. The integration of the service into the clinic fostered the development of a more psychologically minded practice. While highly valued by respondents, potential benefits of the service were limited by residency-specific factors including consultant availability and the high ratio of primary care physicians to consultants.

Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection